Korean firm partners with Sanofi for Parkinson's Disease treatment
Therapeutics | News | 0 Comment | 12 Jan, 2022
ABL Bio, Inc., a South Korea-based clinical-stage biotech developing bispecific antibody technology for immuno-oncology ...Read more
Australia discovers new treatments for infectious diseases
Therapeutics | News | 0 Comment | 11 Jan, 2022
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) in Australia have disc...Read more
Japan develops cancer therapy using on-site synthesis of anti-cancer drugs
Therapeutics | News | 0 Comment | 10 Jan, 2022
An international research group at the RIKEN Cluster for Pioneering Research (CPR) in Japan has successfully treated can...Read more
Rare cancers & rare diseases research receives $63.4M boost in Australia
Therapeutics | News | 0 Comment | 10 Jan, 2022
Research into some of the world’s rarest forms of cancer and disease have received a boost, with the Australian go...Read more
Korea-based LISCure Biosciences explores treatment for rare liver diseases
Therapeutics | News | 0 Comment | 07 Jan, 2022
LISCure Biosciences Inc., a South Korea-based biotech startup, has executed a research collaboration agreement with US b...Read more
Mental health clinical trials receive funding worth $14.8 M in Australia
Therapeutics | News | 0 Comment | 07 Jan, 2022
Seven clinical trials testing the use of potential breakthrough combination therapies to treat debilitating mental illne...Read more
US-based Allay Therapeutics expands operations in Singapore
Therapeutics | News | 0 Comment | 07 Jan, 2022
Allay Therapeutics, a US-based clinical-stage biotechnology company pioneering ultra-sustained analgesic products to tra...Read more
Australia injects $5.5 M for clinical trials to treat low-survival breast cancers
Therapeutics | News | 0 Comment | 06 Jan, 2022
Two clinical trials which could save lives through new therapies to treat breast cancers that have low rates of survival...Read more
Korean firms to develop new compounds for potential anti-seizure medication
Therapeutics | News | 0 Comment | 05 Jan, 2022
BIORCHESTRA and SK Biopharmaceuticals, based in South Korea, have forged a partnership to research and develop new ...Read more
Korean firm GC Cell to expand availability of Immuncell-LC for liver cancer
Therapeutics | News | 0 Comment | 04 Jan, 2022
South Korea-based GC Cell and Indian firm Rivaara Immune have entered into an exclusive licensing agreement, pursuant to...Read more
Japan opts for drug repurposing to stop dementia
Therapeutics | News | 0 Comment | 01 Jan, 2022
Via drug repositioning, a team of scientists at the Osaka City University in Japan has created a combination of rifampic...Read more
Australia identifies drivers of kidney disease
Therapeutics | News | 0 Comment | 28 Dec, 2021
For the first time, researchers from Australian National University have identified a gene which shows the kidney has it...Read more
Hong Kong establishes Centre for Chinese Herbal Medicine Drug Development
Therapeutics | News | 0 Comment | 27 Dec, 2021
Hong Kong Baptist University (HKBU) has established the Centre for Chinese Herbal Medicine Drug Development (CDD), which...Read more
Australia forms world-first consortium to fight global blindness
Therapeutics | News | 0 Comment | 27 Dec, 2021
Australian leaders in corneal bioengineering have collaborated to form BIENCO, a consortium to develop bioengineered eye...Read more
Nasal spray to fight COVID-19 heads to clinical trial in Australia
Therapeutics | News | 0 Comment | 24 Dec, 2021
An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the Univer...Read more
Australia links walking style with ‘future osteoarthritis’
Therapeutics | News | 0 Comment | 23 Dec, 2021
The way people move and unconsciously place pressure on certain joints when walking could play a role in future onset an...Read more
New Zealand confirms skin infections as cause of rheumatic fever
Therapeutics | News | 0 Comment | 22 Dec, 2021
Researchers at University of Otago in New Zealand have made a major breakthrough in further understanding acute rheumati...Read more
One antibody to neutralise both Zika & Dengue viruses in different ways: Singapore study
Therapeutics | News | 0 Comment | 21 Dec, 2021
A research team from the Department of Biological Sciences and the Duke-NUS Medical School, National University of Singa...Read more